A Single-arm Phase II Clinical Trial of Serplulimab Combined With Concurrent Chemoradiotherapy for Limited-stage Small Cell Lung Cancer(LS-SCLC)
Latest Information Update: 25 Jul 2024
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Etoposide (Primary) ; Serplulimab (Primary) ; Sintilimab (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 22 Jul 2024 Status changed from not yet recruiting to recruiting.
- 08 Mar 2024 New trial record